) -- Shares of

OncoGenex Pharmaceuticals



) were gapping down Friday morning with an open price 19.7% lower than Thursday's closing price. The stock closed at $17.43 Thursday and opened today's trading at $13.99.

The average volume for OncoGenex has been 40,700 shares per day over the past 30 days. OncoGenex has a market cap of $133.8 million and is part of the

health care

sector and


industry. Shares are up 48.5% year to date as of the close of trading on Thursday.

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.

TheStreet Recommends

TheStreet Ratings rates OncoGenex as a


. Among the areas we feel are negative, one of the most important has been weak operating cash flow. You can view the full

OncoGenex Ratings Report


Get more investment ideas from our

investment research center


Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options